巨輪智能(002031.SZ):新推出的智能伺服液壓硫化機新產品,可通過物聯網模塊與輪胎廠MES系統組網
格隆匯9月20日丨巨輪智能(002031.SZ)於2023年9月19日召開業績説明會,就“公司液壓式硫化機業務毛利率有所回升,上半年公司硫化機業務有何進展”,公司回覆稱,2023年上半年,公司研發推出的液壓式硫化機產品被廣東省工業和信息化廳授予“2022年省級製造業單項冠軍產品”稱號。新推出的智能伺服液壓硫化機新產品,可通過物聯網模塊與輪胎廠MES系統組網。實現全參數化控制硫化機的運行過程,無需人工操作,大大縮短硫化輔助及更換模具輔助的時間;實現全自動物流及硫化機生產過程的智能化網絡羣控,是未來輪胎企業無人工廠的理想裝備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.